Quantitative Preclinical Imaging of TSPO Expression in Glioma Using N,N-Diethyl-2-(2-(4-(2-18F-Fluoroethoxy)Phenyl)-5,7-Dimethylpyrazolo[1,5-a]Pyrimidin-3-yl)Acetamide

Dewei Tang; Matthew R. Hight; Eliot T. McKinley; Allie Fu; Jason R. Buck; R. Adam Smith; Mohammed Noor Tantawy; Todd E. Peterson; Daniel C. Colvin; M. Sib Ansari; Michael Nickels; H. Charles Manning

doi:10.2967/jnumed.111.095653

Research ArticleBasic Science Investigations

Quantitative Preclinical Imaging of TSPO Expression in Glioma Using N,N-Diethyl-2-(2-(4-(2-¹⁸F-Fluoroethoxy)Phenyl)-5,7-Dimethylpyrazolo[1,5-a]Pyrimidin-3-yl)Acetamide

Dewei Tang, Matthew R. Hight, Eliot T. McKinley, Allie Fu, Jason R. Buck, R. Adam Smith, Mohammed Noor Tantawy, Todd E. Peterson, Daniel C. Colvin, M. Sib Ansari, Michael Nickels and H. Charles Manning

Journal of Nuclear Medicine February 2012, 53 (2) 287-294; DOI: https://doi.org/10.2967/jnumed.111.095653

Dewei Tang

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Matthew R. Hight

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Eliot T. McKinley

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Allie Fu

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jason R. Buck

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

R. Adam Smith

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Mohammed Noor Tantawy

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Todd E. Peterson

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Daniel C. Colvin

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

M. Sib Ansari

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Michael Nickels

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

H. Charles Manning

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Data supplements

Supplemental Data

Files in this Data Supplement:

Supplemental Data

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 53, Issue 2

February 1, 2012

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Quantitative Preclinical Imaging of TSPO Expression in Glioma Using N,N-Diethyl-2-(2-(4-(2-18F-Fluoroethoxy)Phenyl)-5,7-Dimethylpyrazolo[1,5-a]Pyrimidin-3-yl)Acetamide

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Quantitative Preclinical Imaging of TSPO Expression in Glioma Using N,N-Diethyl-2-(2-(4-(2-¹⁸F-Fluoroethoxy)Phenyl)-5,7-Dimethylpyrazolo[1,5-a]Pyrimidin-3-yl)Acetamide

Dewei Tang, Matthew R. Hight, Eliot T. McKinley, Allie Fu, Jason R. Buck, R. Adam Smith, Mohammed Noor Tantawy, Todd E. Peterson, Daniel C. Colvin, M. Sib Ansari, Michael Nickels, H. Charles Manning

Journal of Nuclear Medicine Feb 2012, 53 (2) 287-294; DOI: 10.2967/jnumed.111.095653

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Quantitative Preclinical Imaging of TSPO Expression in Glioma Using N,N-Diethyl-2-(2-(4-(2-¹⁸F-Fluoroethoxy)Phenyl)-5,7-Dimethylpyrazolo[1,5-a]Pyrimidin-3-yl)Acetamide

Dewei Tang, Matthew R. Hight, Eliot T. McKinley, Allie Fu, Jason R. Buck, R. Adam Smith, Mohammed Noor Tantawy, Todd E. Peterson, Daniel C. Colvin, M. Sib Ansari, Michael Nickels, H. Charles Manning

Journal of Nuclear Medicine Feb 2012, 53 (2) 287-294; DOI: 10.2967/jnumed.111.095653

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

This Month in JNM

PubMed
Google Scholar

Cited By...

TSPO-targeted PET and Optical Probes for the Detection and Localization of Premalignant and Malignant Pancreatic Lesions
Combined PET Imaging of the Inflammatory Tumor Microenvironment Identifies Margins of Unique Radiotracer Uptake
Imaging Microglial Activation with TSPO PET: Lighting Up Neurologic Diseases?
TSPO as a target for glioblastoma therapeutics
The 18-kDa Mitochondrial Translocator Protein in Human Gliomas: An 11C-(R)PK11195 PET Imaging and Neuropathology Study
Glial Activation in the Early Stages of Brain Metastasis: TSPO as a Diagnostic Biomarker
The Translocator Protein Radioligand 18F-DPA-714 Monitors Antitumor Effect of Erufosine in a Rat 9L Intracranial Glioma Model

Google Scholar

Main menu

User menu

Search

Quantitative Preclinical Imaging of TSPO Expression in Glioma Using N,N-Diethyl-2-(2-(4-(2-¹⁸F-Fluoroethoxy)Phenyl)-5,7-Dimethylpyrazolo[1,5-a]Pyrimidin-3-yl)Acetamide

Data supplements

Supplemental Data

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles